Literature DB >> 15773542

[Why ribonucleases cause death of cancer cells].

O N Il'inskaia, A A Makarov.   

Abstract

Molecular properties and possible mechanisms of action of cytotoxic ribonucleases (RNases), potential antitumor therapeutics, are characterized. The analysis of recent publications and own experimental results have allowed the authors, on the one hand, to distinguish cellular components that are responsible for selective activity of exogenous RNases towards malignant cells, and on the other--to identify the contribution of definite molecular determinants to the enzyme cytotoxicity. The predominant effect of the RNase molecule charge on the cell death induction is shown. The RNase cytotoxic effects are caused by catalytic cleavage of available RNA, by products of its hydrolysis, as well as by non-catalytic electrostatic interaction of exogenous enzyme with cell components. Potential targets for RNase action in a cancer cell have been revealed. The role of modulation of the membrane calcium-dependent potassium channels and ras-oncogene functions in the RNase-induced cell damage is defined. The effect of cytotoxic RNases on gene expression via influencing the RNA interference is discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15773542

Source DB:  PubMed          Journal:  Mol Biol (Mosk)        ISSN: 0026-8984


  3 in total

1.  Gel-based oligonucleotide microarray approach to analyze protein-ssDNA binding specificity.

Authors:  Olga A Zasedateleva; Andrey L Mikheikin; Alexander Y Turygin; Dmitry V Prokopenko; Alexander V Chudinov; Elena E Belobritskaya; Vladimir R Chechetkin; Alexander S Zasedatelev
Journal:  Nucleic Acids Res       Date:  2008-05-12       Impact factor: 16.971

2.  Binase treatment increases interferon sensitivity and apoptosis in SiHa cervical carcinoma cells by downregulating E6 and E7 human papilloma virus oncoproteins.

Authors:  Vladimir A Mitkevich; Ksenia M Burnysheva; Irina Yu Petrushanko; Alexei A Adzhubei; Alexey A Schulga; Peter M Chumakov; Alexander A Makarov
Journal:  Oncotarget       Date:  2017-08-10

3.  The systemic tumor response to RNase A treatment affects the expression of genes involved in maintaining cell malignancy.

Authors:  Nadezhda Mironova; Olga Patutina; Evgenyi Brenner; Alexander Kurilshikov; Valentin Vlassov; Marina Zenkova
Journal:  Oncotarget       Date:  2017-08-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.